American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a beneficial ownership statement with the SEC on November 16, 2026, disclosing a combined 5.3% stake in Koppers Holdings Inc. common stock as of September 30, 2026.
Key Highlights
- Three reporting persons: American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each reported identical beneficial ownership figures in the joint filing.
- Aggregate beneficial ownership: 1,007,792 shares of Koppers Holdings Inc. common stock are reported by each of the three filers.
- Ownership percentage: The 1,007,792 shares represent 5.3% of the outstanding class of common stock, according to the filing.
- Sole voting and dispositive power: All 1,007,792 shares are held with sole voting power and sole dispositive power; shared voting and shared dispositive power are each reported as 0.
- Triggering event date: The date of the event requiring this filing is stated as September 30, 2026.
- Ordinary course certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
Ownership Structure and Relationships Among the Three Filers
According to the filing, American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of American Century Companies, Inc. ("ACC") and is registered as an investment adviser under Section 203 of the Investment Advisers Act of 1940. ACC is itself controlled by the Stowers Institute for Medical Research, a Delaware-organized entity. This corporate chain explains why all three entities report the same 1,007,792-share position: ACIM acts as the investment adviser managing the shares, while ACC and Stowers Institute appear as parent holding company and control entity, respectively.
The filing discloses that various persons, including investment companies and separate institutional investor accounts that ACIM serves as investment adviser, have the right to receive dividends from or proceeds from the sale of the reported securities. The filing further states that "not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM." Koppers Holdings Inc., the issuer, is headquartered at 436 Seventh Avenue, Pittsburgh, Pennsylvania 15219, and its common stock is listed on the NYSE under the symbol KOP.
The joint filing was signed on November 16, 2026, by John Pak, Senior Vice President of both ACIM and ACC, and by Joselyn Verschelden as Authorized Signer for Stowers Institute for Medical Research. The filing was made pursuant to Rule 13d-1 and covers only the common stock of Koppers Holdings Inc.
What Was Disclosed
Three affiliated entities reported joint beneficial ownership of 1,007,792 shares of Koppers Holdings Inc. common stock, equal to 5.3% of the class, with all voting and dispositive power held solely and no shared interests reported, based on a triggering event of September 30, 2026.




Please wait processing your request...